NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
29/11/2022
Voltar para busca
Dado oficial do USPTO
SUPRAANTIGEN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SUPRAANTIGEN
ST13
US500000088636138Classe
1, 5, 42
Pedido
88636138
Registro
6909261
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
29/11/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
30/09/2019
Data de registro
29/11/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/11/2022
Última transação
29/11/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Lausanne, CH
Examinador
KUMIS, SCOTT N
Unidade examinadora
N90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
AC Immune SA
Representantes
Kristina Montanaro Schrader Adams and Reese LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industry and science; chemical substanceschemical materials and chemical preparationsnatural elementschemical preparations for industrial and scientific purposesother than for medical or veterinary use; chemicalbiochemicalbiological and biotechnological preparations for use in industry and science; proteinprotein fragmentsamino acidsantibodies and fragments thereof for industrialscientific or research purposesother than for medical or veterinary use; chemical preparations comprising small molecules for use in industry and science; molecular librariescomprising libraries of chemical preparations for use in industry and science; small molecule librarycomprising libraries of chemical preparations for use in industry and science; antibody librarycomprising libraries of antibodies for scientific or research use; reagents for use in the development of antibodiesproteins for binding or detecting antibodies and antibody-producing hybridoma cells for scientific or research purposes or for industrial use; detectably labelled compound for industrialscientific purposes; diagnostic reagents for industrialscientific or research purposes; immunological reagents for industrialscientific or research purposes; biological cellbiological tissue culture for use in non-medical research laboratories; diagnostic tools in the nature of preparationscompanion diagnostic agentsbiomarkersimaging agentsPET-Imaging compounds for industrialscientific purposes other than for medical or veterinary use; diagnostic reagents for industrialscientific or research purposes other than for medical or veterinary use
Classe 5
Pharmaceuticalsmedical and veterinary preparations for the diagnosisprevention and treatment of neurodegenerative diseases and inflammatory diseases; diagnostic preparations and materials for medical or veterinary purposes; companion diagnostic agentsbiomarkersimaging agentsPET-Imaging compoundsall for medical purposes; chemical preparations for medical purposesfor the diagnosisprevention and treatment of neurodegenerative diseases and inflammatory diseases; chemico-pharmaceutical preparation for medical purposesfor the diagnosisprevention and treatment of neurodegenerative diseases and inflammatory diseases; antibodiesantibody fragments and antibody derivatives for use in disease testingdiagnosisprevention and treatment for medical purposes; pharmaceutical and medical preparations in the nature of small molecule compounds for medical purposes; PET-Imaging compounds in the nature of diagnostic radiopharmaceutical agents for use in PET imaging; diagnostic preparations in the nature of companion compounds for medical use; pharmaceutical and medical preparations in the nature of biomarkers for medical purposes; vaccines; antigenic peptides for the diagnosisprevention and treatment of neurodegenerative diseases and inflammatory diseases; pharmaceutical and medical preparations in the nature of protein or protein fragments for medical purposes; diagnostic reagents for medical purposes; diagnostic antibodies for medical purposes
Classe 42
Scientific and technological servicesscientific researchanalysis and testing and the development of technology in the field of medicine and pharmaceuticals and research activities relating thereto; providing access to a proprietary technology platform containing antibodiesvaccines and small molecules that gives users the ability to obtain information for research purposes; biological research services; chemical research services in the fields of neurodegenerative diseases and inflammatory diseases; medical research services; scientific and medical laboratory services in biotechnologychemistrypharmacymolecular science and immunotherapy; providing medical and scientific research information in the field of biotechnologychemistrypharmacymolecular scienceimmunotherapytherapeuticsdiagnostics and clinical trials; scientific researchdevelopment and consultancy in the field of biotechnologychemistrypharmacymolecular scienceimmunotherapytherapeuticsdiagnostics and clinical trials; development of test proceduresassaystest reagentsPET-imagingcompanion diagnostic biomarkersantibodiesvaccines and test kits for the field of biotechnologychemistrypharmacymolecular scienceimmunotherapytherapeuticsdiagnostics and clinical trials; biological researchscreening and selection of pharmaceutical active substances from biological and biotechnological preparations; custom design and development of biological assays; research and developmentvaccine and antibody engineering
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
29/11/2022
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
26/10/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
26/10/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
10/10/2022
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
10/10/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/05/2022
EX1G
SOU EXTENSION 1 GRANTED
09/05/2022
EXT1
SOU EXTENSION 1 FILED
09/05/2022
EEXT
SOU TEAS EXTENSION RECEIVED
09/05/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/01/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/01/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/01/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/09/2021
PUBO
PUBLISHED FOR OPPOSITION
14/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/08/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
08/07/2021
ALIE
ASSIGNED TO LIE
06/07/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
13/05/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/08/2020
GNSL
LETTER OF SUSPENSION E-MAILED
05/08/2020
CNSL
SUSPENSION LETTER WRITTEN
05/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/07/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/07/2020
ALIE
ASSIGNED TO LIE
16/07/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/07/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/01/2020
GNRT
NON-FINAL ACTION E-MAILED
07/01/2020
CNRT
NON-FINAL ACTION WRITTEN
07/01/2020
DOCK
ASSIGNED TO EXAMINER
03/01/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/10/2019
NWAP
NEW APPLICATION ENTERED
03/10/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SUPRAANTIGEN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.